JP2007535478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535478A5 JP2007535478A5 JP2006520420A JP2006520420A JP2007535478A5 JP 2007535478 A5 JP2007535478 A5 JP 2007535478A5 JP 2006520420 A JP2006520420 A JP 2006520420A JP 2006520420 A JP2006520420 A JP 2006520420A JP 2007535478 A5 JP2007535478 A5 JP 2007535478A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- formula
- group
- independently selected
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000001424 substituent group Chemical group 0.000 description 9
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 description 1
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 description 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 description 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 1
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 description 1
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48694803P | 2003-07-14 | 2003-07-14 | |
| PCT/US2004/023776 WO2005007652A2 (en) | 2003-07-14 | 2004-07-14 | Substituted quinolin-4-ylamine analogues |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011032423A Division JP2011137018A (ja) | 2003-07-14 | 2011-02-17 | 置換キノリン−４−イルアミン類縁体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007535478A JP2007535478A (ja) | 2007-12-06 |
| JP2007535478A5 true JP2007535478A5 (enExample) | 2011-04-07 |
Family
ID=34079320
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520420A Abandoned JP2007535478A (ja) | 2003-07-14 | 2004-07-14 | 置換キノリン−４−イルアミン類縁体 |
| JP2011032423A Pending JP2011137018A (ja) | 2003-07-14 | 2011-02-17 | 置換キノリン−４−イルアミン類縁体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011032423A Pending JP2011137018A (ja) | 2003-07-14 | 2011-02-17 | 置換キノリン−４−イルアミン類縁体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7488740B2 (enExample) |
| EP (1) | EP1644372A2 (enExample) |
| JP (2) | JP2007535478A (enExample) |
| CN (1) | CN1820008A (enExample) |
| AU (1) | AU2004257296A1 (enExample) |
| CA (1) | CA2531535A1 (enExample) |
| TW (1) | TW200510373A (enExample) |
| WO (1) | WO2005007652A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1581225A1 (en) * | 2002-12-13 | 2005-10-05 | Neurogen Corporation | Combination therapy for the treatment of pain |
| CA2509239A1 (en) * | 2002-12-13 | 2004-07-01 | Neurogen Corporation | Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| TW200510373A (en) * | 2003-07-14 | 2005-03-16 | Neurogen Corp | Substituted quinolin-4-ylamine analogues |
| EP1678173A2 (en) * | 2003-09-09 | 2006-07-12 | Neurogen Corporation | 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists |
| CA2555867A1 (en) * | 2004-03-04 | 2005-09-22 | Neurogen Corporation | Arylalkylamino-substituted quinazoline analogues |
| CN1964717A (zh) * | 2004-04-08 | 2007-05-16 | 神经能质公司 | 经取代∴啉－4－基胺 |
| TW200621251A (en) * | 2004-10-12 | 2006-07-01 | Neurogen Corp | Substituted biaryl quinolin-4-ylamine analogues |
| CA2624307C (en) | 2005-10-07 | 2014-04-29 | Glenmark Pharmaceuticals S.A. | Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| RU2467007C2 (ru) | 2005-12-21 | 2012-11-20 | Эбботт Лэборетриз | Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv |
| EP1971611B1 (en) | 2005-12-21 | 2012-10-10 | Abbott Laboratories | Anti-viral compounds |
| ES2378473T3 (es) | 2005-12-21 | 2012-04-12 | Abbott Laboratories | Compuestos antivirales |
| AU2007325780B9 (en) | 2006-11-27 | 2013-09-12 | H. Lundbeck A/S | Heteroaryl amide derivatives |
| US8236950B2 (en) | 2006-12-20 | 2012-08-07 | Abbott Laboratories | Anti-viral compounds |
| SG157299A1 (en) * | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| US8703962B2 (en) * | 2008-10-24 | 2014-04-22 | Purdue Pharma L.P. | Monocyclic compounds and their use as TRPV1 ligands |
| US8546388B2 (en) * | 2008-10-24 | 2013-10-01 | Purdue Pharma L.P. | Heterocyclic TRPV1 receptor ligands |
| US8759362B2 (en) * | 2008-10-24 | 2014-06-24 | Purdue Pharma L.P. | Bicycloheteroaryl compounds and their use as TRPV1 ligands |
| CA2773713A1 (en) * | 2009-10-07 | 2011-04-14 | Merck Sharp & Dohme Corp. | Novel trpa1 antagonists |
| MX2013010163A (es) | 2011-03-09 | 2013-10-30 | Merck Patent Gmbh | Derivados de pirido[2,3-b] pirazina y sus usos terapeuticos. |
| JP2015521603A (ja) * | 2012-06-15 | 2015-07-30 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 脳癌の新規治療薬 |
| LT3089971T (lt) | 2014-01-01 | 2020-10-12 | Medivation Technologies Llc | Junginiai ir panaudojimo būdai |
| US10227333B2 (en) | 2015-02-11 | 2019-03-12 | Curtana Pharmaceuticals, Inc. | Inhibition of OLIG2 activity |
| AU2016225000B2 (en) * | 2015-02-27 | 2021-04-01 | Curtana Pharmaceuticals, Inc. | Inhibition of Olig2 activity |
| WO2017031427A1 (en) * | 2015-08-19 | 2017-02-23 | 3-V Biosciences, Inc. | COMPOUNDS AND METHODS FOR INHIBITING mTOR |
| EP3929185A4 (en) * | 2019-02-19 | 2023-02-15 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | CONDENSED CYCLIC COMPOUND CONTAINING NITROGEN, METHOD FOR PREPARATION AND USE |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8928281D0 (en) * | 1989-12-14 | 1990-02-21 | Smith Kline French Lab | Compounds |
| GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| AR007857A1 (es) * | 1996-07-13 | 1999-11-24 | Glaxo Group Ltd | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen. |
| CA2260058A1 (en) * | 1996-07-13 | 1998-01-22 | Kathryn Jane Smith | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| HRP970371A2 (en) * | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| US5863016A (en) | 1997-02-28 | 1999-01-26 | The Wiremold Company | Modular faceplate assembly having concealed latching means |
| MA26473A1 (fr) * | 1997-03-01 | 2004-12-20 | Glaxo Group Ltd | Composes pharmacologiquement actifs. |
| RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| KR100736502B1 (ko) | 1998-09-29 | 2007-07-06 | 와이어쓰 홀딩스 코포레이션 | 단백질 티로신 키나제 억제제로서 치환된 3-시아노퀴놀린 |
| GB2345486A (en) * | 1999-01-11 | 2000-07-12 | Glaxo Group Ltd | Heteroaromatic protein tyrosine kinase inhibitors |
| US6521618B2 (en) * | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| KR20030024799A (ko) | 2000-07-20 | 2003-03-26 | 뉴로젠 코포레이션 | 캡사이신 수용체 리간드 |
| US6638926B2 (en) | 2000-09-15 | 2003-10-28 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| WO2003014064A1 (en) * | 2001-07-31 | 2003-02-20 | Bayer Healthcare Ag | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| RS63204A (sr) * | 2002-01-17 | 2006-10-27 | Neurogen Corporation | Supstituisani analozi hinazolin-4-ilamina kao modulatori kapsaicina |
| US7718651B2 (en) * | 2002-07-02 | 2010-05-18 | Southern Research Institute | Inhibitors of FtsZ and uses thereof |
| EP1581225A1 (en) * | 2002-12-13 | 2005-10-05 | Neurogen Corporation | Combination therapy for the treatment of pain |
| CA2509239A1 (en) * | 2002-12-13 | 2004-07-01 | Neurogen Corporation | Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| TW200510373A (en) * | 2003-07-14 | 2005-03-16 | Neurogen Corp | Substituted quinolin-4-ylamine analogues |
| TW200621251A (en) * | 2004-10-12 | 2006-07-01 | Neurogen Corp | Substituted biaryl quinolin-4-ylamine analogues |
| CN101232885A (zh) | 2005-01-25 | 2008-07-30 | 神经能质公司 | 经取代的哒嗪基喹啉-4-基胺和嘧啶基喹啉-4-基胺类似物 |
-
2004
- 2004-07-13 TW TW093120845A patent/TW200510373A/zh unknown
- 2004-07-14 EP EP04779026A patent/EP1644372A2/en not_active Withdrawn
- 2004-07-14 CN CNA2004800197211A patent/CN1820008A/zh active Pending
- 2004-07-14 US US10/891,832 patent/US7488740B2/en not_active Expired - Fee Related
- 2004-07-14 JP JP2006520420A patent/JP2007535478A/ja not_active Abandoned
- 2004-07-14 CA CA002531535A patent/CA2531535A1/en not_active Abandoned
- 2004-07-14 WO PCT/US2004/023776 patent/WO2005007652A2/en not_active Ceased
- 2004-07-14 AU AU2004257296A patent/AU2004257296A1/en not_active Abandoned
-
2009
- 2009-02-09 US US12/368,302 patent/US20090286767A1/en not_active Abandoned
-
2011
- 2011-02-17 JP JP2011032423A patent/JP2011137018A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535478A5 (enExample) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| NO20070032L (no) | Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes | |
| NO20064008L (no) | Forbindelser | |
| JP2012511588A5 (enExample) | ||
| JP2007508359A5 (enExample) | ||
| TW200602028A (en) | Compounds | |
| JP2015535277A5 (enExample) | ||
| JP2019513778A5 (enExample) | ||
| ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
| JP2012512886A5 (enExample) | ||
| JP2007524696A5 (enExample) | ||
| JP2016525075A5 (enExample) | ||
| NO20073926L (no) | Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser | |
| MEP12708A (en) | Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| NO20074311L (no) | Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet | |
| NO20070457L (no) | Pyrazolderivater | |
| JP2007506740A5 (enExample) | ||
| JP2013542213A5 (enExample) | ||
| NO20072053L (no) | Nye bis-azaindolderivater, fremstilling og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JP2015524843A5 (enExample) | ||
| RU2011105059A (ru) | Применение производных пиримидиламинобензамида для лечения фиброза | |
| RU2372348C2 (ru) | Производные индолилмалеимида в качестве ингибиторов ркс | |
| RU2008136892A (ru) | Способ получения соединения 5-алкокси-4-гидроксиметилпиразола |